Today
-1.09%
5 Days
-2.47%
1 Month
-4.70%
6 Months
-4.16%
Year to Date
+6.46%
1 Year
-7.18%
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
The Coca-Cola Company is an American multinational corporation established in 1892. It produces, sells, and markets soft drinks, including Coca-Cola, various non-alcoholic beverage concentrates and syrups, as well as alcoholic drinks. The company's stock is listed on the New York Stock Exchange(NYSE: KO) and is included in the DJIA, S&P 500, and S&P 100 indices.
Coca-Cola was created in 1886 by pharmacist John Stith Pemberton. When it was first introduced, the beverage contained stimulants from coca leaves and caffeine from kola nuts, which worked together synergistically. The names "coca" and "kola" inspired the product's name and led to its marketing as a "healthy tonic." Pemberton, who had been severely injured during the American Civil War, developed an addiction to morphine pain medication. During that period, cocaine was promoted as a remedy for opioid addiction, prompting him to create the beverage as a patent medicine aimed at managing his dependence.
In 1889, Asa Griggs Candler purchased the formula and brand for $2,300, subsequently incorporating the Coca-Cola Company in Atlanta, Georgia, in 1892. The company has utilized a franchised distribution system since 1889, primarily producing syrup concentrate, which is sold to various bottlers worldwide who operate within exclusive territories.
TradingKey - In Q2 2025, Coca-Cola reported revenue of $12.5 billion, up 1.54% year-over-year, slightly below market expectations of $12.55 billion. Organic revenue grew 5%, driven primarily by a 6% price/mix increase, though this was partially offset by a 1% decline in concentrate sales...
TradingKey - As more U.S. companies release their Q2 2025 earnings, a clear trend is emerging: the weaker U.S. dollar is helping to offset the negative impact of Trump’s tariffs on multinational corporations — creating a favorable chain reaction of currency tailwinds, stronger earnings, and rising
TradingKey - As of March 31, 2025, Warren Buffett’s Berkshire Hathaway holds a $258.7 billion equity portfolio spread across 36 stocks. The Oracle of Omaha hasn’t made a new buy this quarter, and turnover remains minimal at 1%.
TradingKey - On initial inspection, Coca-Cola's Q1 2025 results look ordinary. Net revenues declined 2%, North American volumes decreased 3%, and comparable EPS increased only 1% to $0.73 on the back of industry-leading operating margin growth.
April 29 (Reuters) - Coca-Cola's KO.N quarterly revenue and profit beat estimates on Tuesday thanks to price hikes and strong demand for its sodas, but the beverage giant warned U.S. tariffs could impact costs and hurt consumer sentiment going ahead.
Shares in Coca-Cola KO.N lose a little fizz in broader market decline, down ~0.7% on Monday; Q1 report due before market open on Tuesday.Wall Street sees the soft drinks co reporting adj EPS of $0.71 vs $0.72 in year-ago quarter on rev of $11.14 bln vs $11.23 bln year-ago, according to latest d...
The Coca-Cola Company is an American multinational corporation established in 1892. It produces, sells, and markets soft drinks, including Coca-Cola, various non-alcoholic beverage concentrates and syrups, as well as alcoholic drinks. The company's stock is listed on the New York Stock Exchange(NYSE: KO) and is included in the DJIA, S&P 500, and S&P 100 indices.
Coca-Cola was created in 1886 by pharmacist John Stith Pemberton. When it was first introduced, the beverage contained stimulants from coca leaves and caffeine from kola nuts, which worked together synergistically. The names "coca" and "kola" inspired the product's name and led to its marketing as a "healthy tonic." Pemberton, who had been severely injured during the American Civil War, developed an addiction to morphine pain medication. During that period, cocaine was promoted as a remedy for opioid addiction, prompting him to create the beverage as a patent medicine aimed at managing his dependence.
In 1889, Asa Griggs Candler purchased the formula and brand for $2,300, subsequently incorporating the Coca-Cola Company in Atlanta, Georgia, in 1892. The company has utilized a franchised distribution system since 1889, primarily producing syrup concentrate, which is sold to various bottlers worldwide who operate within exclusive territories.